LAV leads $50m Series B funding in Chinese drug maker Link Pharmaceuticals

New investors New Alliance Capital and Hangzhou Heda Industry Fund participated in the funding round.

Related Keywords

Kaitai ,Guizhou ,China ,Japan ,Shanghai ,United States ,Ting Feng ,Hainan ,Zheshang ,Zhejiang ,Hangzhou ,Kobe ,Hyogo ,American , ,Zheshang Group ,Lynk Pharmaceuticals Co ,Lynk Pharmaceuticals ,Valliance Capital ,Hangzhou Heda Industry Fund ,Lilly Asia Ventures ,New Alliance Capital ,Legend Capital ,Med Fine Capital ,East China ,Kaitai Capital ,Sinopharm Capital ,